Magazine Article | February 1, 2021

My Journey From Skepticism To Conviction Regarding AI

Source: Life Science Leader

By Mark Eller

Drug development is a complex, highly regulated practice that relies, most importantly, on experiments and their results.

The initial discovery step relies on human insight to generate hypotheses worth testing in the first experiments. Insights come through knowledge, experience, patience and instinct. Best practices are handed down from researcher to researcher, which in turn helps companies build and refine their hypotheses and grow their pipelines. That has been the traditional path to drug discovery. Another is that computers and artificial intelligence (AI) can replace this traditional model and expedite the entire process. The dichotomy between these two approaches is very real.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: